118 related articles for article (PubMed ID: 6660675)
1. [Neuroblastoma. Therapeutic considerations].
Sánchez de Toledo Codina J; Prats Villas J
An Esp Pediatr; 1983 Sep; 19 Suppl 19():81-4. PubMed ID: 6660675
[No Abstract] [Full Text] [Related]
2. Neuroblastoma sympathicum.
Koutecký J
Acta Univ Carol Med Monogr; 1984; 106():1-133. PubMed ID: 6391118
[No Abstract] [Full Text] [Related]
3. Genomic and metabolic aspects of neuroblastomas in children under one year of age.
Nakagawara A; Zaizen Y; Suita S
Prog Clin Biol Res; 1991; 366():115-25. PubMed ID: 2068132
[No Abstract] [Full Text] [Related]
4. Autologous bone marrow transplantation for very bad prognosis neuroblastoma.
Philip T; Biron P; Philip I; Favrot M; Bernard JL; Zucker JM; Lutz B; Plouvier E; Rebattu P; Carton M
Prog Clin Biol Res; 1985; 175():569-86. PubMed ID: 3887433
[No Abstract] [Full Text] [Related]
5. Metastatic neuroblastoma managed by supralethal therapy and bone marrow reconstitution (BMRc). Results of a four-institution Children's Cancer Study Group pilot study.
D'Angio GJ; August C; Elkins W; Evans AE; Seeger R; Lenarsky C; Feig S; Wells J; Ramsay N; Kim T
Prog Clin Biol Res; 1985; 175():557-63. PubMed ID: 3887431
[No Abstract] [Full Text] [Related]
6. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
[TBL] [Abstract][Full Text] [Related]
7. 3F8 monoclonal antibody treatment of patients with stage IV neuroblastoma: a phase II study.
Cheung NK; Kushner BH; Yeh SJ; Larson SM
Prog Clin Biol Res; 1994; 385():319-28. PubMed ID: 7972227
[No Abstract] [Full Text] [Related]
8. High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification.
Laprie A; Michon J; Hartmann O; Munzer C; Leclair MD; Coze C; Valteau-Couanet D; Plantaz D; Carrie C; Habrand JL; Bergeron C; Chastagner P; Défachelles AS; Delattre O; Combaret V; Bénard J; Pérel Y; Gandemer V; Rubie H;
Cancer; 2004 Sep; 101(5):1081-9. PubMed ID: 15329919
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
[TBL] [Abstract][Full Text] [Related]
10. [Management strategy in neuroblastoma].
Balwierz W
Przegl Lek; 2004; 61 Suppl 2():3-8. PubMed ID: 15686038
[TBL] [Abstract][Full Text] [Related]
11. [Neuroblastoma. Results of protocol N-I-87].
Castel Sánchez V; Badal Iranzo MD; Bezanilla Regato JL; Herrero Díez A; Llombart Bosch A; Ruiz Jiménez JI; Sánchez de Toledo J
An Esp Pediatr; 1993 May; 38(5):471-6. PubMed ID: 8503598
[No Abstract] [Full Text] [Related]
12. Teniposide, doxorubicin, melphalan, cisplatin, and total body irradiation with autologous bone marrow transplantation for advanced neuroblastoma.
Lam-Po-Tang PR; McCowage GB; Vowels MR
Transplant Proc; 1993 Oct; 25(5):2881-2. PubMed ID: 8212272
[No Abstract] [Full Text] [Related]
13. Myeloablative chemoradiotherapy versus continued chemotherapy for high risk neuroblastoma.
Stram DO; Matthay KK; O'Leary M; Reynolds CP; Seeger RC
Prog Clin Biol Res; 1994; 385():287-91. PubMed ID: 7972222
[No Abstract] [Full Text] [Related]
14. Rethinking management of localized neuroblastoma.
Kushner BH; LaQuaglia MP; Cheung NK
J Clin Oncol; 1993 Sep; 11(9):1832-4. PubMed ID: 8257505
[No Abstract] [Full Text] [Related]
15. Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution.
Hartmann O; Valteau-Couanet D; Vassal G; Lapierre V; Brugières L; Delgado R; Couanet D; Lumbroso J; Benhamou E
Bone Marrow Transplant; 1999 Apr; 23(8):789-95. PubMed ID: 10231141
[TBL] [Abstract][Full Text] [Related]
16. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
[TBL] [Abstract][Full Text] [Related]
18. [Systemic therapy in children and adolescents].
Kremens B
Urologe A; 2007 Oct; 46(10):1404-6. PubMed ID: 17823786
[TBL] [Abstract][Full Text] [Related]
19. [Neuroblastoma].
Sawada T; Komatsu H; Shirai C; Yamamoto S; Ishiwari K; Ishida H; Ohmizono Y; Matsumura T
Gan To Kagaku Ryoho; 1995 Jan; 22(1):28-36. PubMed ID: 7826075
[TBL] [Abstract][Full Text] [Related]
20. [Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children].
Tang SQ; Huang DS; Wang JW; Feng C; Yang G
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):93-6. PubMed ID: 16613697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
